122 related articles for article (PubMed ID: 769221)
21. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
[TBL] [Abstract][Full Text] [Related]
22. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
23. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
[TBL] [Abstract][Full Text] [Related]
24. Post-transplant monitoring of renal allograft recipients for T, B and null lymphocyte subpopulations.
Sengar DP; Rashid A; Harris JE
Clin Exp Immunol; 1977 Apr; 28(1):123-9. PubMed ID: 140776
[TBL] [Abstract][Full Text] [Related]
25. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
[TBL] [Abstract][Full Text] [Related]
26. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
27. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
Dickmeiss E
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
[TBL] [Abstract][Full Text] [Related]
28. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
[TBL] [Abstract][Full Text] [Related]
29. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy.
Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK
Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170
[TBL] [Abstract][Full Text] [Related]
30. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
31. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
Cantarovich D
J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.
Waer M; Vanrenterghem Y; Ang KK; Van der Schueren E; Michielsen P; Vandeputte M
J Immunol; 1984 Feb; 132(2):1041-8. PubMed ID: 6228588
[TBL] [Abstract][Full Text] [Related]
33. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
34. Preoperative single-bolus high-dose antithymocyte globulin as induction therapy in sensitized renal transplant recipients.
Wang D; Wu WZ; Yang SL; Chen JH; Tan JM
Chin Med J (Engl); 2006 Oct; 119(20):1683-8. PubMed ID: 17097014
[TBL] [Abstract][Full Text] [Related]
35. Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.
Rashid A; Sengar DP; Harris JE
Clin Exp Immunol; 1979 Jun; 36(3):521-7. PubMed ID: 158449
[TBL] [Abstract][Full Text] [Related]
36. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
[TBL] [Abstract][Full Text] [Related]
37. Acute cellular rejection and humoral sensitization in lung transplant recipients.
Martinu T; Howell DN; Palmer SM
Semin Respir Crit Care Med; 2010 Apr; 31(2):179-88. PubMed ID: 20354931
[TBL] [Abstract][Full Text] [Related]
38. An assessment of cell-mediated immunity in acute allograft rejection in man. A prospective study.
Buckingham JM; Ritts RE; Woods JE; Ilstrup DM
Mayo Clin Proc; 1977 Feb; 52(2):101-5. PubMed ID: 344999
[TBL] [Abstract][Full Text] [Related]
39. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
Sengar DP; Rashid A; Harris JE
Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
[TBL] [Abstract][Full Text] [Related]
40. Renal transplantation and viral infections. IV. A survey of herpes simplex virus excretion in relation to cellular specific immunity and humoral immunity among renal transplant recipients.
Fortier B; Nicolas JC; Burguière AM; Huraux JM; Bricout F
Biomedicine; 1978 Dec; 28(6):328-32. PubMed ID: 371689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
